Citation: Sj. Shen et al., CYTOCHROME P4502C11 IS A TARGET OF DICLOFENAC COVALENT BINDING IN RATS, Chemical research in toxicology, 10(4), 1997, pp. 420-423
Authors:
ATCHISON CR
HARGUS SJ
ARONSON JF
HOFFMANN WE
DAIKER DH
POHL LR
WEST AB
MOSLEN MT
Citation: Cr. Atchison et al., DICLOFENAC DECREASES SERUM ALKALINE-PHOSPHATASE ISOZYMES AND FORMS PROTEIN ADDUCTS IN MULTIPLE TISSUES, Hepatology, 24(4), 1996, pp. 1361-1361
Citation: Sj. Hargus et al., COVALENT MODIFICATION OF RAT-LIVER DIPEPTIDYL PEPTIDASE-IV (CD26) BY THE NONSTEROIDAL ANTIINFLAMMATORY DRUG DICLOFENAC, Chemical research in toxicology, 8(8), 1995, pp. 993-996
Authors:
HARGUS SJ
AMOUZEDEH HR
PUMFORD NR
MYERS TG
MCCOY SC
POHL LR
Citation: Sj. Hargus et al., METABOLIC-ACTIVATION AND IMMUNOCHEMICAL LOCALIZATION OF LIVER PROTEINADDUCTS OF THE NONSTEROIDAL ANTIINFLAMMATORY DRUG DICLOFENAC, Chemical research in toxicology, 7(4), 1994, pp. 575-582
Citation: Lr. Pohl et al., IMMUNOCHEMICAL METHODS OF STUDYING THE MECHANISM OF DICLOFENAC-INDUCED ARTHRITIS, Arthritis and rheumatism, 37(7), 1994, pp. 1112-1112
Citation: Lr. Pohl et al., IMMUNOCHEMICAL METHODS OF STUDYING THE MECHANISM OF DICLOFENAC-INDUCED HEPATITIS (VOL 37, PG 1112, 1994), Arthritis and rheumatism, 37(10), 1994, pp. 1557-1557